The Male Reproductive Toxicity Caused by 2-Naphthylamine Was Related to Testicular Immunity Disorders.

2-naphthylamine immunity lipid metabolism malformation sperm motility testis

Journal

Toxics
ISSN: 2305-6304
Titre abrégé: Toxics
Pays: Switzerland
ID NLM: 101639637

Informations de publication

Date de publication:
07 May 2024
Historique:
received: 06 04 2024
revised: 28 04 2024
accepted: 06 05 2024
medline: 24 5 2024
pubmed: 24 5 2024
entrez: 24 5 2024
Statut: epublish

Résumé

2-naphthylamine (NAP) was classified as a group I carcinogen associated with bladder cancer. The daily exposure is mostly from cigarette and E-cigarette smoke. NAP can lead to testicular atrophy and interstitial tissue hyperplasia; however, the outcomes of NAP treatment on spermatogenesis and the associated mechanisms have not been reported. The study aimed to investigate the effect of NAP on spermatogenesis and sperm physiologic functions after being persistently exposed to NAP at 5, 20, and 40 mg/kg for 35 days. We found that sperm motility, progressive motility, sperm average path velocity, and straight-line velocity declined remarkably in the NAP (40 mg/kg) treated group, and the sperm deformation rate rose upon NAP administration. The testis immunity- and lipid metabolism-associated processes were enriched from RNA-sequence profiling.

Identifiants

pubmed: 38787121
pii: toxics12050342
doi: 10.3390/toxics12050342
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Nantong Social and People's Livelihood Science and Technology Plan
ID : MS22022119 and MS22022087

Auteurs

Pengyuan Dai (P)

Institute of Reproductive Medicine, Medical School, Nantong University, Nantong 226019, China.

Mengqian Ding (M)

Institute of Reproductive Medicine, Medical School, Nantong University, Nantong 226019, China.

Jingyan Yu (J)

Institute of Reproductive Medicine, Medical School, Nantong University, Nantong 226019, China.

Yuan Gao (Y)

Experimental Animal Center, Nantong University, Nantong 226001, China.

Miaomiao Wang (M)

Institute of Reproductive Medicine, Medical School, Nantong University, Nantong 226019, China.

Jie Ling (J)

Institute of Reproductive Medicine, Medical School, Nantong University, Nantong 226019, China.

Shijue Dong (S)

Institute of Reproductive Medicine, Medical School, Nantong University, Nantong 226019, China.

Xiaoning Zhang (X)

Institute of Reproductive Medicine, Medical School, Nantong University, Nantong 226019, China.

Xuhui Zeng (X)

Institute of Reproductive Medicine, Medical School, Nantong University, Nantong 226019, China.

Xiaoli Sun (X)

Center for Reproductive Medicine, The Affiliated Hospital of Nantong University, Nantong University, Nantong 226001, China.

Classifications MeSH